bivalirudin and Diabetic-Angiopathies

bivalirudin has been researched along with Diabetic-Angiopathies* in 2 studies

Other Studies

2 other study(ies) available for bivalirudin and Diabetic-Angiopathies

Article	Year
Bilateral adrenal hemorrhages in a patient with heparin-induced thrombocytopenia. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2019, Nov-04, Volume: 191, Issue:44 Topics: Adrenal Gland Diseases; Aged; Anticoagulants; Atrial Fibrillation; Diabetic Angiopathies; Hemorrhage; Heparin; Hirudins; Humans; Hydrocortisone; Hypotension; Male; Non-ST Elevated Myocardial Infarction; Peptide Fragments; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vasoconstrictor Agents	2019
Direct thrombin inhibitors. The Journal of invasive cardiology, 2004, Volume: 16, Issue:7 Suppl Bivalent direct thrombin inhibitors reduce ischemic risk compared to heparin. Results from randomized, double-blind clinical trials have demonstrated that bivalirudin is superior to heparin alone and as effective as heparin plus routine glycoprotein (GP) IIb/IIIa therapy for the prevention of ischemic events with a statistically significant reduction in the rate of in-hospital major bleeding. Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Antithrombins; Clinical Trials as Topic; Coronary Disease; Costs and Cost Analysis; Diabetic Angiopathies; Hirudins; Humans; Peptide Fragments; Recombinant Proteins; Risk Assessment; Treatment Outcome	2004

Article

Year

Bilateral adrenal hemorrhages in a patient with heparin-induced thrombocytopenia.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2019, Nov-04, Volume: 191, Issue:44

Topics: Adrenal Gland Diseases; Aged; Anticoagulants; Atrial Fibrillation; Diabetic Angiopathies; Hemorrhage; Heparin; Hirudins; Humans; Hydrocortisone; Hypotension; Male; Non-ST Elevated Myocardial Infarction; Peptide Fragments; Recombinant Proteins; Thrombocytopenia; Treatment Outcome; Vasoconstrictor Agents

2019

Direct thrombin inhibitors.

The Journal of invasive cardiology, 2004, Volume: 16, Issue:7 Suppl

Bivalent direct thrombin inhibitors reduce ischemic risk compared to heparin. Results from randomized, double-blind clinical trials have demonstrated that bivalirudin is superior to heparin alone and as effective as heparin plus routine glycoprotein (GP) IIb/IIIa therapy for the prevention of ischemic events with a statistically significant reduction in the rate of in-hospital major bleeding.

Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Antithrombins; Clinical Trials as Topic; Coronary Disease; Costs and Cost Analysis; Diabetic Angiopathies; Hirudins; Humans; Peptide Fragments; Recombinant Proteins; Risk Assessment; Treatment Outcome

2004